CA50904-2 - 0x00000000000072B0

Healthy Males & Females

Vast

* Stipend may pay up to reflected amount.
Start Date: 
October 25, 2026 - 2:45pm
End Date: 
November 15, 2026 - 8:15am

Study Details

Study Number: CA50904
Group Number: 2
Study Requirement: Healthy Normal Male and Female
Stipend: up to $10,500.00

Study Criteria

Age: 19 - 50
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat Type 1 diabetes.
Route of Administration: Oral
Blood Draws: 39

Study Schedule

Schedule Type: Long Term
Study Length: 15 Night Stay & 5 Returns

Screening Dates:

Event Day Event Date
Friday 10/16/2026
Wednesday 10/21/2026
Thursday 10/22/2026
Friday 10/23/2026
Saturday 10/24/2026

Doctor Exam Dates:

Event Day Event Date
Friday 10/16/2026
Wednesday 10/21/2026
Thursday 10/22/2026
Friday 10/23/2026
Saturday 10/24/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Sunday 10/25/2026 2:45:00 PM Monday 11/9/2026 8:15:00 AM 1 Lincoln
Return Tuesday 11/10/2026 7:15:00 AM Tuesday 11/10/2026 8:15:00 AM 1 Lincoln
Return Wednesday 11/11/2026 7:15:00 AM Wednesday 11/11/2026 8:15:00 AM 1 Lincoln
Return Thursday 11/12/2026 7:15:00 AM Thursday 11/12/2026 8:15:00 AM 1 Lincoln
Return Friday 11/13/2026 7:15:00 AM Friday 11/13/2026 8:15:00 AM 1 Lincoln
Return Sunday 11/15/2026 7:15:00 AM Sunday 11/15/2026 8:15:00 AM 1 Lincoln